Serum platelet-activating factor acetylhydrolase (PAF-AH) activity in more than 3000 healthy Japanese

被引:25
|
作者
Kosaka, T
Yamaguchi, M
Miyanaga, K
Mizuno, K
机构
[1] Azwell Inc, Nesco Co, Diagnost Res & Dev Dept, Div Res & Dev, Osaka 5670806, Japan
[2] Gunma Mental Hlth Ctr, Gunma 3792166, Japan
关键词
platelet-activating factor acetylhydrolase; serum; healthy Japanese; age; sex; human; plasma;
D O I
10.1016/S0009-8981(01)00612-X
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: A spectrophotometric assay for platelet-activating factor acetylhydrolase (PAF-AH) activity differs from the radioisotopic assay in its value because of a difference in substrate specificity. The spectrophotometric assay is more precise than the radioisotopic assay, providing information that is not clear with the radioisotopic assay, Methods: We measured the serum PAF-All activity in 3106 healthy Japanese, utilizing the spectrophotometric assay with an Hitachi 7170 automatic analyzer. We also measured the serum PAF-AH activity in 18 healthy volunteers to investigate the effect of diet and the change in activity in a day and over 6 weeks. Changes were examined at 0 (day 1), 1, 2, 4 and 6 weeks. Results: The mean value for females was significantly lower than that of males at the 5% level and both male and female activity had a tendency to increase with advancing age. It is known that the PAF-AH is primarily associated with LDL in blood and the PAF-All activity correlated with the total cholesterol (r = 0.52, n = 126) and the LDL cholesterol (r = 0.60, n = 126) concentrations. In the diet study, there was no observable effect on activity. No difference in PAF-AH activity was observed between serum and plasma sample types. The serum PAF-AH activity was stable at 7 degreesC for at least 7 days and at -20 degreesC for at least 2 months. Conclusions: The serum PAF-AH activity in women was lower than in men until the menopausal age was reached. We could use not only fresh fasting serum, but also plasma sample, non-fasting sample and stored sample to estimate the PAF-AH activity. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:179 / 183
页数:5
相关论文
共 50 条
  • [11] Decreased Expression in Platelet-Activating Factor Acetylhydrolase (PAF-AH) Gene Is Associated with ARDS
    Tejera-Alvarez, P.
    Zhang, R.
    Su, L.
    Christiani, D. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [12] Two novel mutations in the plasma platelet-activating factor acetylhydrolase (PAF-AH) gene identified in Japanese subjects
    Ishihara, M
    Nagano, M
    Iwasaki, T
    Kujiraoka, T
    Ishii, J
    Tsuji, M
    Ito, M
    Kumagai, T
    Egashira, T
    Hattori, H
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 330 - 330
  • [13] Platelet activating factor (PAF) and PAF-acetylhydrolase (PAF-AH) activity in necrotizing enterocolitis (NEC).
    Contador, M
    Moya, F
    Zhao, BR
    Frenkel, R
    Weinberg, A
    Guzzetta, P
    Johnston, JM
    PEDIATRIC RESEARCH, 1996, 39 (04) : 1200 - 1200
  • [14] Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2)
    Stafforini, Diana M.
    CARDIOVASCULAR DRUGS AND THERAPY, 2009, 23 (01) : 73 - 83
  • [15] PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE (PAF-AH) IN HUMAN KIDNEY
    ANTONOPOULOU, S
    DEMOPOULOS, CA
    IATROU, C
    MOUSTAKAS, G
    ZIROGIANNIS, P
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1994, 26 (09): : 1157 - 1162
  • [16] Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2)
    Diana M. Stafforini
    Cardiovascular Drugs and Therapy, 2009, 23 : 73 - 83
  • [17] Glycaemic control reduces the platelet-activating factor acetylhydrolase activity (PAF-AH activity) in type 2 diabetes mellitus
    Cubero, J.
    Vinagre, I.
    Sanchez-Quesada, J.
    Sanchez-Hernandez, J.
    Santos, L.
    Blanco-Vaca, F.
    Ordonez-Llanos, J.
    Perez, A.
    DIABETOLOGIA, 2009, 52 : S521 - S521
  • [18] Influence of genetic variants on the activity of platelet-activating-factor acetylhydrolase (PAF-AH)
    Hoffmann, M
    Simon, M
    Winkelmann, B
    Boehm, B
    Maerz, W
    Winkler, K
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 7 - 7
  • [19] Bacterial Clearance Is Improved in Septic Mice by Platelet-Activating Factor-Acetylhydrolase (PAF-AH) Administration
    Teixeira-da-Cunha, Mariana G. A.
    Gomes, Rachel N.
    Roehrs, Nathassia
    Bozza, Fernando A.
    Prescott, Stephen M.
    Stafforini, Diana
    Zimmerman, Guy A.
    Bozza, Patricia T.
    Castro-Faria-Neto, Hugo C.
    PLOS ONE, 2013, 8 (09):
  • [20] Measurement of plasma platelet-activating factor acetylhydrolase (PAF-AH) concentrations in hyperlipidemia and diabetes by sandwich ELISA
    Kujiraoka, T
    Ishihara, M
    Iwasaki, T
    Ito, M
    Kawaguchi, A
    Tsuji, M
    Ishii, J
    Egashira, T
    Miller, NE
    Hattori, H
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 329 - 329